Home/Pipeline/Neurodegenerative Diseases Biomarker Services

Neurodegenerative Diseases Biomarker Services

Alzheimer's Disease, Parkinson's Disease

Service OfferingActive

Key Facts

Indication

Alzheimer's Disease, Parkinson's Disease

Phase

Service Offering

Status

Active

Company

The Siesta Group

About The Siesta Group

The Siesta Group is a Vienna-based, neuroscience-focused service provider that empowers CNS drug development through advanced analysis of EEG, sleep, and activity data. Leveraging over 20 years of experience, proprietary AI-powered analysis tools, and a strong scientific network, the company helps sponsors identify biomarkers and endpoints for conditions ranging from sleep disorders to neurodegenerative diseases. It operates as a trusted partner to over 30 leading sponsors and CROs, offering a full suite of clinical trial services from feasibility to data visualization, all while maintaining rigorous compliance standards.

View full company profile

Therapeutic Areas

Sleep Disorders Sleep Apnea Neurodegenerative Diseases Mood Disorders Schizophrenia Autism Anxiety Disorders

Other Alzheimer's Disease, Parkinson's Disease Drugs

Drug	Company	Phase	Status
Undisclosed Neurodegeneration Program(s)	Muna Therapeutics	Preclinical	Active
DJ-1 / PARK7 Program	Cantabio Pharmaceuticals	Pre-clinical	Active
Undisclosed Neurodegeneration Program	Sitala Bio	Pre-clinical	Active